High throughput profiling of the B cell repertoire identifies systematic changes in the repertoire of individuals with Crohn’s disease
Authors:
- Aya K.H. MahdyAMAya K.H. Mahdy
- Zahra TaheriZTZahra Taheri
- Marte Lie HøivikMHMarte Lie Høivik
- Andre FrankeAFAndre Franke
- Hesham ElAbdHEHesham ElAbd
Preprint
Abstract
The B cell repertoire contains the recombined DNA sequences that encodes the entire antibody repertoire of an individual. The repertoire is made from three antigenic binding chains, namely the immunoglobulin heavy chain (IGH) and two immunoglobulin light chains, κ (IGK) and λ (IGL). Compared to the T cell repertoire, the B cell repertoire is understudied in inflammatory bowel diseases (IBD) even though different antibodies such as ASCA and ANCA have been shown to be elevated in individuals with IBD. Furthermore, most IBD B cell repertoire studies have profiled the repertoire of treated individuals, thus capturing the combined effect of treatment and disease on the repertoire. To address this limitation, we profiled the repertoire of 24 treatment-naive individuals with CD with matching 24 symptomatic controls. The repertoire of individuals with CD showed a significant reduction in diversity and an increase in clonality, suggesting an antigen-driven expansion of clonotypes that might be driving the disease. Furthermore, we observed a significant reduction in the expansion of IgM and IgD and an expansion of IgA2 and IgG2 clonotypes in individuals with CD relative to controls. Lastly, we observed a reduction in the somatic hypermutation rate in the IGH J gene, particularly in IgM and IgA1 clonotypes, among individuals with CD relative to controls. Thus, despite the small sample size, we identified multiple alterations in the B cell repertoire of individuals with CD, highlighting the potential of the B cell repertoire in identifying antigenic exposures implicated in the diseases, demanding now larger international studies ideally including also treatment-naive and pre-clinical cases.Keywords
All Related Versions
- Published version: Frontiers in Immunology, 17.
Funding Information
- EU Horizon Europe Program (miGut-Health)
- Deutsche Forschungsgemeinschaft (Research Unit 5042)
- Deutsche Forschungsgemeinschaft (Cluster of Excellence 2167)
- Deutsche Forschungsgemeinschaft (collaborative research center 1526)
This publication has 29 references indexed in Scilit:
- Disease-specific B cell clones are shared between patients with Crohn’s diseaseNature Communications, 2025
- Bulk T cell repertoire sequencing (TCR-Seq) is a powerful technology for understanding inflammation-mediated diseasesJournal of Autoimmunity, 2024
- Risk of inflammatory bowel disease following hospitalisation with infectious mononucleosis: nationwide cohort study from DenmarkNature Communications, 2024
- Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signaturesImmunity, 2023
- Escherichia coli–Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s DiseaseCellular and Molecular Gastroenterology and Hepatology, 2020
- Analysis of the B cell receptor repertoire in six immune-mediated diseasesNature, 2019
- MiXCR: software for comprehensive adaptive immunity profilingNature Methods, 2015
- High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitisNature Genetics, 2015
- A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1Nature Genetics, 2006
- Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populationsThe Lancet, 2001